Nocopi Technologies Reports Third Quarter Results
Nocopi Technologies (NNUP) reported a significant revenue increase of 119% in Q3 2022, reaching $685,900 compared to $312,500 in Q3 2021. This growth is driven by higher ink shipments and a renewed international license agreement. Excluding this license revenue, Q3 revenue rose 42% to $444,900. Gross profit also saw a 136% increase, totaling $493,500, with a gross profit margin of 72%. Net income improved to $206,500. The company continues to face supply chain challenges but aims to stabilize operations and pursue growth opportunities.
- Revenue increased 119% to $685,900 in Q3 2022.
- Gross profit rose 136% to $493,500, with a margin of 72%.
- Net income improved significantly to $206,500 from $1,100 in Q3 2021.
- Cash and equivalents reached $5.35 million after private placement.
- Appointment of Matthew Winger as Executive VP to enhance business development.
- Ongoing supply chain disruptions affecting product sales.
- Operating expenses increased by 31% due to non-recurring legal fees.
KING OF PRUSSIA, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks today announced results for its third quarter and nine months ended September 30, 2022. Nocopi’s SEC filings are available here.
2022 Q3 Results
2022 Q3 revenue was
Year to date, product sales through 2022 Q3 continue to be impacted by ongoing congestion experienced in certain Chinese ports from the COVID-19 outbreak and other supply chain disruptions resulting from the lockdowns in certain Asian cities that affect business and production.
Gross profit increased
2022 Q3 operating expenses increased
Net income for the quarter was
Highlights
- Quarterly revenue of
$685,900 including the license fee renewal of an existing international licensee agreement for a five-year extension, and quarterly net income of$206,500. - Ended the quarter with cash and cash equivalents of
$5.35 million , increased by both cash flow from operations and private placement proceeds of$3.5 million . No placement fees or commissions were paid in connection with the private placement. - Completed a 1-for-10 reverse stock split during the quarter resulting in 9,251,178 outstanding shares as of November 1, 2022.
- Appointed Michael S. Liebowitz to the board of Directors, increasing the board to six directors, three of whom have been added over the last twelve months.
- Named Matthew Winger as Executive Vice President of Corporate Development to lead business development initiatives, financial planning, and other strategic activities.
Commentary
Nocopi Chairman and CEO Michael Feinstein commented, “Our third quarter sales showed continuing signs of recovery compared to last year. We are working to overcome the remaining headwinds from the global supply chain disruptions and lockdowns. Although this was our second quarter in a row of a continued recovery in our base of business, we are confident that these headwinds will eventually fully subside and believe our business will return to historical demand patterns.
Importantly, over the past quarter, we have been focusing on improving our internal operations. We have expanded our executive team with the appointment of Matthew Winger as Executive Vice President of Corporate Development, as well our board of directors with the appointment of Michael S. Liebowitz. We have started strengthening our relationships with existing customers and have begun new efforts to increase our outreach to new customers and markets.
Our long-term strategic plan remains focused on generating free cash flow through our disciplined cost management and capital allocation plans. Having recently closed on the private placement funding, we are actively focused on pursuing accretive opportunities.
About Nocopi Technologies (www.nocopi.com)
Nocopi Technologies, headquartered in King of Prussia, PA develops and markets specialty reactive inks and licenses these technologies. Nocopi’s ink technologies are backed by proprietary and patented technology. Our inks are marketed for use across a variety of end markets.
Safe Harbor for Forward-Looking Statements
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. . Forward-looking statements involve a number of estimates, assumptions, risks and uncertainties that may cause actual results to differ materially from those anticipated. Forward-looking statements may address uncertainties regarding customer preferences or demand for products incorporating Nocopi technology that underlie the company’s revenue expectations, the company’s ability to develop new products and new product applications, the financial condition of customers and the timeliness of their payments, the impact of fluctuations in currencies, global trade and shipping markets, etc. Actual results could differ from those projected due to numerous factors and uncertainties, and Nocopi can give no assurance that such statements will prove to be correct nor that Nocopi’s actual results of operations, financial condition and performance will not differ materially from those reflected or implied by its forward-looking statements. Investors should refer to the risk factors outlined in Nocopi’s Form 10-K and other SEC reports available at www.sec.gov/edgar. Forward-looking statements are made as of the date of this news release; Nocopi assumes no obligation to update these statements.
Investor & Media Contacts
610-834-9600
ir@nocopi.com
FAQ
What were Nocopi Technologies' Q3 2022 revenues and profits?
How much did Nocopi's revenue grow compared to Q3 2021?
What challenges is Nocopi facing in its operations?
What was Nocopi's gross profit margin in Q3 2022?
Who has been appointed to lead strategic initiatives at Nocopi?
